Nutritional considerations for older adults with type 2 diabetes.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 19042580)

Published in J Nutr Elder on January 01, 2008

Authors

Andrea R Josse1, Shirin Panahi, Amin Esfahani, Lawrence A Leiter, David J A Jenkins, Cyril W C Kendall

Author Affiliations

1: Clinical Nutrition and Risk Factor Modification Center, St. Michael's Hospital and Department of Nutritional Sciences, Faculty of Medicine, University of Tornoto, 150 College Street, Toronto, Ontario, Canada.

Articles by these authors

Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34

Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93

Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol (2006) 6.09

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol (2013) 5.97

Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet (2013) 5.44

Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38

Egg yolk consumption and carotid plaque. Atherosclerosis (2012) 4.20

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.14

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr (2008) 3.33

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26

Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA (2008) 3.25

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA (2003) 3.03

The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med (2009) 2.68

Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med (2012) 2.58

Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med (2012) 2.54

Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA (2011) 2.47

Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr (2003) 2.45

Glycemic index: overview of implications in health and disease. Am J Clin Nutr (2002) 2.43

Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol (2010) 2.23

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J (2009) 2.21

A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care (2006) 2.15

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01

Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care (2002) 1.88

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85

Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension (2012) 1.84

Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr (2005) 1.80

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol (2006) 1.67

A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr (2009) 1.62

Carbohydrate-induced memory impairment in adults with type 2 diabetes. Diabetes Care (2003) 1.61

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care (2013) 1.56

Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis (2006) 1.56

Contemporary management of dyslipidemia in high-risk patients: targets still not met. Am J Med (2006) 1.54

Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr (2004) 1.53

The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism (2003) 1.49

Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr (2006) 1.47

Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care (2012) 1.45

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2010) 1.44

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol (2009) 1.42

Too much sugar, too much carbohydrate, or just too much? Am J Clin Nutr (2004) 1.42

Methodology for adding glycemic load values to the National Cancer Institute Diet History Questionnaire database. J Am Diet Assoc (2006) 1.40

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2011) 1.38

Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks. J Am Diet Assoc (2008) 1.38

Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation (2002) 1.37

D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition (2008) 1.35

Are dietary recommendations for the use of fish oils sustainable? CMAJ (2009) 1.35

The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr (2012) 1.32

Type 2 diabetes and the vegetarian diet. Am J Clin Nutr (2003) 1.31

Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial. Eur J Endocrinol (2012) 1.26

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2008) 1.25

Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease. Curr Opin Clin Nutr Metab Care (2003) 1.24

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol (2011) 1.24

Role of cell walls in the bioaccessibility of lipids in almond seeds. Am J Clin Nutr (2004) 1.23

Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr (2010) 1.20

Carbohydrate digestibility and metabolic effects. J Nutr (2007) 1.19

Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care (2009) 1.18

Retracted Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care (2011) 1.17

Almonds and postprandial glycemia--a dose-response study. Metabolism (2007) 1.17

Hypertension in people with type 2 diabetes: Update on pharmacologic management. Can Fam Physician (2011) 1.17

Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr (2012) 1.17

Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts. J Am Heart Assoc (2012) 1.16

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada. Eur J Prev Cardiol (2011) 1.16

Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ (2011) 1.12

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Curr Opin Cardiol (2006) 1.12

Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ (2010) 1.12

Health effects of mixed fruit and vegetable concentrates: a systematic review of the clinical interventions. J Am Coll Nutr (2011) 1.10

Hypertension in diabetes: a call to action. Can J Cardiol (2009) 1.10

Overstated associations between fructose and nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2015) 1.09

Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr (2002) 1.09

Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease. Am J Cardiol (2008) 1.09

Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ (2008) 1.08

Vegetarian and vegan diets in type 2 diabetes management. Nutr Rev (2009) 1.07